How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
- 1 June 2011
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 70 (6) , 1010-1015
Abstract
Objective To estimate the sick leave and disability pension trajectory in patients diagnosed with early rheumatoid arthritis (RA) 1999–2007, and in prevalent patients in 2007. Methods Individuals aged 19–59 years diagnosed with early RA were identified in the Swedish Rheumatology Quality Register (1999–2007; n=3029; 47 years; 73% women). Additionally, prevalent patients in 2007 were identified in the National Patient Register (n=25 922; 52 years; 73% women). For each patient, five age-, sex-, education- and county-matched general population comparators were sampled. Sick leave and disability pension days were retrieved from national registers. Results Sick leave and disability pension increased from a mean 43 to 77 days/year from 2 to 1 years before RA diagnosis. A further increase to 147 days/year was observed the next year, followed by a rebound to 116 days/year 4 years after diagnosis. During the 4 years following diagnosis, sick leave decreased from a mean 118 to 35 and disability pension increased from 29 to 81 days/year. In the prevalent RA population, patients had a mean 158 annual days of sick leave and disability pension compared to 71 in comparators. Large variations existed across age, sex and education level, but RA patients had consistently higher levels. In 2007, the costs associated with sick leave and disability pension were €16 000 per patient with €9 000 attributable to RA. Conclusion Despite better drugs and improved treatment strategies, data from contemporary patients with early and established RA continue to indicate large unmet needs.Keywords
This publication has 23 references indexed in Scilit:
- The combined effects of overweight and smoking in late adolescence on subsequent disability pension: a nationwide cohort studyInternational Journal of Obesity, 2009
- Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspectiveRheumatology, 2007
- Work disability among two cohorts of women with recent‐onset rheumatoid arthritis: A survival analysisArthritis Care & Research, 2007
- Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community‐derived population in Malmö, SwedenScandinavian Journal of Rheumatology, 2007
- Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project)Rheumatology, 2005
- Systematic review of studies of productivity loss due to rheumatoid arthritisOccupational Medicine, 2005
- Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five‐year randomized followup trialArthritis & Rheumatism, 2004
- Association between etanercept use and employment outcomes among patients with rheumatoid arthritisArthritis & Rheumatism, 2003
- Economic burden of rheumatoid arthritis: a systematic reviewRheumatology, 2000
- Length of Life and Cause of Death in Rheumatoid ArthritisNew England Journal of Medicine, 1953